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Abstract Cancer is known to be a multi-step process,
which involves different stages including initiation, pro-
motion, progression and metastasis. Chemical carcinogens
including most trace elements can change any of these
processes to induce their carcinogenic effects. Various
studies confirm that cancer arises from the accumulation of
irreversible DNA damage, which results from multiple
mutations in critical genes in the body organ. Chemical
carcinogens most often directly or after xenobiotic
metabolism, act as genotoxic causes to induce DNA
damage. Genotoxic carcinogen refers to a group of chem-
icals capable of producing cancer by directly altering the
genetic material of target cells. Other carcinogens are
however classified as non-genotoxic, which represents
chemicals that are capable of producing cancer by some
secondary mechanism not related to direct gene damage.
They act as tumor promoters, endocrine-modifiers, receptor
mediators, immunosuppressant, or inducers of tissue-spe-
cific toxicity and inflammatory responses. The diversity of
modes of action, of non-genotoxic carcinogens, the tissue
and species specificity and the absence of genotoxicity
makes it extremely hard to predict their carcinogenic
potential. The roles of trace metals (some of which are
either genotoxic or non-genotoxic) in cancer development
and inhibition have a complex character and have raised
many questions because of their essential and toxic effects
on people’s health. Trace metals such as cadmium, nickel,
arsenic, beryllium and chromium (VI) have been recog-
nized as human or animal carcinogens by International
Agency for Research on Cancer (IARC). The Carcinogenic
capability of these metals depends mainly on factors such
as oxidation states and chemical structures. The oxidative
concept in metal carcinogenesis proposes that complexes
formed by these metals, in vivo, in the vicinity of DNA,
catalyze redox reactions, which in turn oxidize DNA. The
most significant effect of reactive oxygen species in the
carcinogenesis progression is DNA damage, which results
in DNA lesions like strand breaks and the sister-chromatid
exchange. This article reviews the carcinogenicity of var-
ious trace elements.
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Introduction
Carcinogenic substances are those that induce tumors
(benign or malignant), increase their incidence or malig-
nancy or shorten the time of tumor occurrence when they
get into the body through inhalation, injection, dermal
application or ingestion (Maurici et al. 2005, p. 177).
Carcinogens are classified as either genotoxic or non-
genotoxic depending on their modes of action. Genotoxic
carcinogens are those which initiate carcinogenesis by
direct interaction with DNA, resulting in DNA damage or
chromosomal aberrations that can be detected by geno-
toxicity tests (OECD 2006). On the other hand, non-
genotoxic carcinogens are agents that indirectly interact
with the DNA, causing indirect modification to DNA
structure, amount, or function that may result in altered
gene expression or signal transduction (OECD 2006).
Substances that induce tumors in animals are also consid-
ered human carcinogens until proven otherwise (UNECE
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2004, p. 167). All known human carcinogens that have
been evaluated adequately in animal bioassays have been
found to be also carcinogenic in animal bioassay studies. In
fact, it has been reported that of the nearly 100 known
genotoxic and non-genotoxic human carcinogens, one-third
were shown first to be carcinogenic in animals (Huff
1999a, b). Other studies have demonstrated a strong cor-
relation between carcinogenic potencies estimated from
epidemiological data and those from animal carcinogenesis
bioassays (Allen et al. 1988; Goodman and Wilson 1991).
These observations have been used as guidelines to avoid
human exposure to such chemicals found to be carcino-
genic in laboratory animals.
According to evaluations done by the International
Agency for Research on Cancer (IARC), carcinogenicity
data reviewed of various trace elements are classified as:
(i) sufficient, when a casual association is established
between exposure to an agent and human cancer; (ii) lim-
ited, when an association has been observed but chance,
bias, and confounding cannot be ruled out and (iii) inade-
quate, when the data are of insufficient quality, consistency
or statistical power to allow a conclusion (IARC 1989). In
the IARC evaluations, carcinogenicity of chemicals is
categorized according to the following groups:
• Group 1: Carcinogens to humans, when the evidence is
sufficient (105 agents). These comprise 61 chemicals, 9
viruses or pathogens (i.e. HIV), 16 mixtures (i.e. coal-
tars) and 19 exposure circumstances (i.e. chimney
sweeping).
• Group 2A: Probably carcinogenic to humans, mainly
for experimental carcinogens with limited data to
humans (66 agents). These comprise 50 chemicals, 2
viruses or pathogens, 7 mixtures and 7 exposure
circumstances.
• Group2B: Possibly carcinogenic to humans, mainly for
experimental carcinogens with less than limited evi-
dence from humans and less than sufficient evidence
from animals (248 agents). These comprise 224 chem-
icals 4 viruses or pathogens, 13 mixtures and 7
exposure circumstances.
• Group 3: Not classifiable as to its carcinogenicity to
humans, for agents that do not fall into any other
category (515 agents). These comprise 496 chemicals,
11 mixtures and 8 exposure circumstances.
Speciation remains the main methodological method
problem of data review on the carcinogenicity of trace
elements. Just a few compounds within the family (clas-
sification) have available data in most cases, and these
compounds may sometimes not be the most relevant with
regards to human exposure. For instance, epidemiological
studies on occupationally exposed persons may not give
conclusive effects to exposure to individual chemicals
within the family. This is confounded by the fact that the
effect of non-occupational exposures like smoking is rarely
taken into consideration.
The questionable relevance of the route of exposure (e.g.
subcutaneous or intramuscular administration) in animal
experiments makes the use of data derived from such
experiments problematic. The degree of solubility of
chemical exposure, which influences biological effects as
well as the long- or short-term experimental studies must
be taken into account while deciding carcinogenicity
classifications. Certain trace elements like zinc and sele-
nium have been found to have anti-carcinogenic effect
where as others tend to be carcinogenic in specific organs
while showing no such effect in certain organs. No formal
evaluation of anti-carcinogenic effects of these trace ele-
ments has been made by IARC. Table 1 below shows the
summary of the IARC evaluations of the carcinogenicity of
trace elements and other related compounds as detailed in
the preamble of the volumes of the IARC monograph series
(IARC 1993).
The carcinogenic capability of trace metals depends
mainly on factors such as oxidation states and chemical
structures. The oxidative concept in metal carcinogenesis
signifies that complexes formed by these metals, in vivo, in
the vicinity of DNA, catalyze redox reactions, which in
turn oxidize DNA. The most significant effect of reactive
oxygen species (ROS) in the carcinogenesis progression is
DNA damage, which results in DNA lesions like strand
breaks and the sister-chromatid exchange (Valco et al.
2005). It has been estimated that approximately 2 9 104
DNA damaging events occur in every cell per day (Ames
and Shigenaga 1992); a major portion of these occur via
ROS. Similarly, ROS damage results in lipid peroxidation
and depletion of protein sulfhydryls. Even though the
increase in oxidative DNA lesions has been frequently
attributed to metal exposures, it is important to note that
the molecular mechanism leading to tumor formation
after such exposures is still not well understood. The
metal carcinogenesis is mediated either by the increased
generation of ROS on the basis of ESR spin trapping
studies or by interference with the repair process of DNA
(Mehmet 2006). Some oxygen species are worst carcin-
ogenic molecules. There is a very fine balance between
enzymatic [such as superoxide dismutase (SOD), gluta-
thione peroxidase and catalase] and non-enzymatic (such
as ascorbic acid, a-tocopherol, b-carotene and isoflavons)
antioxidants and free radicals in each cell. When ROS
production is higher than the cell reduction capabilities,
they can induce lipid peroxidation, depletion of the sulf-
hydryl groups, change signal transduction pathways, cal-
cium homeostasis and DNA damage (Valco et al. 2005).
This may result in occurrence of aging effect and cancer
infection.
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Free radicals that contain ROS are chemical compounds
that posses one or more electrons in their outer orbital,
while non-radical species have the electron pairs with anti-
parallel spin. The electron transfer reaction in the cell is
responsible for the production of free radicals. Superoxide
anion (O2
-), which occurs about 2–5 % by transformation
of O2 consumed by mitochondria and endoplasmic reticu-
lum, is one of the major radical species. The other major
radical species includes hydrogen peroxide (H2O2), which
is generated spontaneously via reaction between superox-
ide anion and hydrogen cation, by means of SOD in bio-
logical systems (Augusto and Rhian 2011). Other radicals
includes: the highly reactive hydroxyl radical (OH) and
peroxyl radicals (ROO-), hyperchloride (HOCl), alkoxyl
radical (RO), thiyl radical (RS) and nitric oxide (NO).
The ROS occurring in a given cell depends on the metal
species: For example, arsenic-mediated generation of ROS
involves generation of superoxide (O2
-), peroxyl radical
(ROO), nitric oxide (NO), hydrogen peroxide (H2O2) and
dimethylarsinic peroxyl radical ((CH3)2AsOO). In the
absence of the metal catalysts, superoxide and hydrogen
peroxide can be briefly ineffective (Mehmet 2006). Con-
sequently, the protective enzymes such as SOD, catalase
and glutathione peroxidase can moderate the effects of
ROS.
It is important to note that despite their toxic effects,
trace metals in right proportion and concentration, are
essential to normal human homeostasis. The four main
functions of essential trace metals include: (i) stabilizers,
(ii) elements of structure, (iii) essential elements for hor-
monal function and (iv) co-factors in enzymes. The cell
structure alone or structural function due to lack of sta-
bilization, change of charge properties and allosteric con-
figuration can be affected by inadequate supply or lack of
essential trace elements (Mehmet 2006). Some trace ele-
ments play a major role as enzyme co-factors, for instance
SOD are a group of metallo-enzymes (containing Fe, Mn,
or Cu and Zn) that catalyze the disproportionate of super-
oxide free radical (O2
-) to form hydrogen peroxide and
dioxygen. These enzymes constitute the defense system
against the cytotoxic superoxide free radical. Cu, Zn-SOD,
which is a prototypical dinuclear metalloprotein, is an
important antioxidant enzyme for cellular protection from
ROS and several proteins involved in DNA repair (Auld
2001; Ho 2004). Metallothionein (MT) is a transition
metal-binding protein that is found in all eukaryotes (cells
with nucleus) and in some prokaryotes. MT plays a role in
the homeostasis of essential metals such as zinc and cop-
per, detoxification of toxic metals such as cadmium, and
protection against oxidative stress. Due to MT’s important
role in transcription factor regulation, problems with MT
function or expression may lead to malignant transforma-
tion of cells and even cancer. Copper plays a role in
activation of more than 30 enzymes which includes
caeruloplasmine, cytochrome oxidase, lysine oxidase,
dopamine-hydroxylase, ascorbate oxidase and tyrosinase
among others in the body, some of which is involved in the
synthesis of the main component of connective tissues
Table 1 IARC evaluations made of the carcinogenicity of trace elements and related compounds to humans by the international agency of
research on cancer (IARC 1993)
Group 1: carcinogenic to humans Group 2A: probably
carcinogenic












As Arsenic and its compounds Pl Cisplatin Sb Antimony trioxide Sb Antimony trisulfide
Be Beryllium and its
compounds
– – Co Cobalt and its
compounds
Cr Metallic and trivalent
chromium
compounds
Cd Cadmium and its
compounds





– – Ni Metallic nickel Fe Ferric oxide and
hematite
Ni Nickel compounds – – – – Pb Organic lead
compounds
– – – – – – Hg Metallic and inorganic
mercury compounds
– – – – – – Se Selenium and its
compounds
– – – – – – Ti Titanium dioxide
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called collagen. Iron too plays a significant role in oxygen
transportation, xenobiotic metabolism, oxidative phos-
phorylation and act as prosthetic group in many enzymes
(Anil et al. 2011).
The purpose of this review is to discuss the carcinogenic
role of trace elements and the possibility of using their
assay in biological fluids for diagnostic or prognostic
purposes in cancer patients. The review will look into
experimental results of previous works and discuss the
possibility of variations in trace elemental concentrations
obtained.
Carcinogenicity of trace elements
Arsenic and arsenic compounds
Arsenic occurs mostly as a metal arsenide in sulfur-con-
taining ores. It is distributed widely in natural waters but in
some locations it is added to the environment through the
use of certain insecticides and the combustion of fossil
fuels. In the natural waters, arsenic occurs in oxidation
states III and V in form of arsenous acid (H3AsO3) and
arsenic acid (H3AsO5) and their salts, respectively (Sawyer
et al. 2003). As determined by IARC report, arsenic and its
compounds are highly carcinogenic to humans. Skin cancer
and lung cancer have been reported in patients treated with
inorganic trivalent arsenic compounds, drinking water with
high levels of arsenic and those with occupational expo-
sures to inorganic arsenic compounds in mining and copper
smelting industries, respectively (Boffetta 1993). Other
cancers liked to arsenic toxicity include kidney and bladder
(ATSDR 2003). The toxicity of arsenic and its inorganic
compounds has been classified as: acute toxicity, sub-
chronic toxicity, genetic toxicity, developmental and
reproductive toxicity (Chakraborti et al. 2004); immuno-
toxicity (Sakurai et al. 2004); biochemical and cellular
toxicity (Mudhoo et al. 2001). The toxicity of inorganic
arsenic can induce oxidative stress leading to the inhabi-
tation of DNA repair. It has been reported that arsenic-
induced oxidative stress also causes DNA strand breaks,
alkali-labile sites, which eventually results into DNA
adducts (Pu et al. 2007). Arsenic mediation can also alter
methylation status of oncogenes and tumor suppressor
genes and in the processes enhancing carcinogenesis
(Reichard and Puga 2010).
Drinking contaminated ground water with elevated
arsenic levels is the main source of exposure to humans
across the globe, but in particular in South Asia. The
resulting widespread carcinogenic effects on human health
led to the recommendation by USEPA to reduce the
drinking water maximum contaminant limit to 0.010 mg/L
in line with the WHO guidelines (USEPA 2005). In Asian
countries, arsenic compounds have been introduced in the
food chain through uptake by rice plans in the irrigation
fields. However, the major source of arsenic in human food
is the fish and seafood. It was reported that there was a link
between pancreatic cancer and arsenic exposure among
children who consumed arsenic contaminated powdered
milk (Yurifuji et al. 2011). Other studies have shown that
the organic form of arsenic in the food substances is not as
much harmful as the inorganic forms ingested in drinking
waters. Organo-arsenic intake of about 0.05 mg/kg body
weight was found to have less toxic effect (Uneyama et al.
2007).
A systematic assessment of cofactors associated with
increased arsenic-induced cancer risk has been done. It was
established that arsenical skin lesions (i.e., melanosis,
leucomelanosis and keratosis) are a hallmark of chronic
arsenic toxicity. These skin lesions may appear within a
few years of exposure unlike other arsenic-induced can-
cers, which have a longer latency (i.e., decades). These
studies show that the risk of arsenic-induced skin lesions
and cancers is greater among men than in women. Other
variables including cigarette smoking and ultraviolet radi-
ation have been identified as independent risk factors of
non-melanoma skin cancer, and contributors to the higher
risk of arsenic-related skin lesions in men. In addition,
occupational exposures, nutritional habits, socioeconomic
status, and genetic factors, have also been shown to influ-
ence the of arsenic exposure effects on skin lesions and
cancer (Ahsan et al. 2003a, b; Chen et al. 2006).
Beryllium and beryllium compounds
Beryllium (Be) occurs naturally in the form of beryllium
aluminum silicate (beryl), 3BeOAl2O36SiO2. Its naturally
present in rocks, coal and oil, soil and volcanic dust
(ATSDR 2008).There are over 40 known beryllium-bear-
ing minerals, however, only beryl and bertrandite
(4BeO2SiO2H2O) are commercially vital. Beryl contains
ca. 11 % beryllium oxide while Bertrandite contains less
than 1 % beryllium, which can be processed into beryllium
hydroxide. Beryllium forms alloys with many metals
making them much stronger, with high electrical and
thermal conductivity as well as high resistance to corrosion
and fatigue. These properties make beryllium an important
component of wide range of industrial applications
including electronics and weaponry among others.
Occupational exposure to beryllium had been shown to
contribute to an upward trend and reported deaths from
lung cancer developed by those who had had beryllium-
induced respiratory distress. Liver cancer and pancreatic
cancer was also reported to be high among those exposed
(Stoeckle and Mancuso 1974). According to IARC reports,
beryllium inhalation by experimental animals, intratracheal
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studies on rats, intrabronchial studies on monkeys and
intravenous or intramedullary administration to rabbits
showed sufficient evidence of carcinogenicity to beryllium
and its compounds (Boffetta 1993). The increased risk of
carcinogenesis to the exposure to beryllium and beryllium
compounds made it to be classified as one of the most
carcinogens (group 1) to human by IARC.
The binding of ionic beryllium to nucleic acids cause
genetic transformation in mammalian cells which may
result into infidelity of DNA replication (Leonard and
Lauwerys 1987). This genetic transformation is likely to
cause lung cancer to the exposed individuals. A high rel-
ative risk of up to 2.3 would likely cause acute beryllium
pneumonitis, which is linked to higher lung cancer rates
(Steenland and Ward 1991). The same study has shown
that the probability of contracting lung cancer is increased
among those with acute beryllium disease (standard mor-
tality ratio, SMR = 2.32) than in those with chronic
beryllium disease (CBD) (SMR = 1.57) (Steenland and
Ward 1991). A report on carcinogens indicated that the
exposure to beryllium and its compounds caused the
growth of lung tumors in rats that were exposed through a
single intratracheal instillation or a 1-h inhalation (Second
Annual Report 1981). The same report also stated that
monkeys exposed to beryllium oxide and beryllium sulfate
through intrabronchial implantation or inhalation devel-
oped anaplastic carcinoma where as rabbits exposed to
beryllium metal, beryllium carbonate, beryllium oxide,
beryllium phosphate, beryllium silicate or zinc beryllium
silicate by intravenous injection and/or bone implantation
developed osteosarcoma (Second Annual Report 1981).
The immunological behavior of T lymphocytes (T cells,
which play a central role in cell-mediated immunity) fol-
lowing beryllium exposure has been explained in terms of
toxic kinetic and toxic dynamic effects, for instance, 70 %
of the total beryllium, that is, 10–100 ng/g serum was
detected in pre-albumin and clinical studies of acute
beryllium disease, respectively (Stiefel et al. 1980; Cooper
and Harrison 2009). The programmed death pathway (PD-
1) is active in beryllium-induced disease and significantly
control beryllium-induced T cell proliferation (Palmer
et al. 2008). Studies have shown that beryllium exposure in
the cell mediates a thiol imbalance that leads to oxidative
stress, which in turn may transform the proliferation and
clonal expansion of CD4? T cells (Dobis et al. 2008).
Beryllium-induced proliferation of T lymphocytes from the
lungs of a CBD patients are associated with human leu-
kocyte antigens (HLA-DP) alleles which posses a glutamic
acid in the 69th position of the B1 chain of this molecule
(Fontenot et al. 1999; Wang et al. 2001). It has been found
that exposure to beryllium-ferritin cause the production of
persistent antigen, which is linked to the chronicity of CBD
and its development even years after one had been exposed
(Cooper and Harrison 2009). Since the presence of circu-
lating beryllium-specific CD4? T cells directly correlates
with the severity of lymphocytic alveolitis, studies show
that there is a great increase in antigen-specific effecter
memory CD4? T cells in the lungs of CBD patients
(Fontenot et al. 2002).
Cadmium and cadmium compounds
Cadmium is naturally present in air, soils sediments and
even unpolluted sea water. It is emitted to the air by mines,
metal smelters and industries, which use cadmium com-
pounds for alloys, batteries, pigments and plastics (Harri-
son 2001). It is a widespread environmental and industrial
pollutant, which has been declared carcinogen by Interna-
tional Agency for Cancer Research (IARC 1993). All
forms of tobacco contains an appreciable amount of cad-
mium making tobacco smoking, both active and passive,
the largest single source of human exposure to cadmium
and in effect its carcinogenic effect. The smoking effects
are pronounced by the fact that the absorption of cadmium
from the lungs into the body cells is much greater than the
gastrointestinal tract absorption (Figueroa 2008; Ming-Ho
2005). Since cadmium ions are readily absorbed by plants
and stored in the stem, leaves and fruits, which animals can
feed on, affected animal and plant food products also acts
as the sources of cadmium to humans. Only inorganic
cadmium salts are present in food products. Cadmium
accumulation has been reported in milk and animal fatty
tissues (Figueroa 2008) and sea foods such as mollusks and
crustaceans (Castro-Gonza´lez and Me´ndez-Armenta 2008;
WHO 2004b, 2006). EPA recommendation for maximum
contaminant level of cadmium in drinking water is
0.005 mg/L while recommended a lower level of
0.003 mg/L (WHO 2004a).
Animal-based studies have reported carcinogenic effects
from cadmium exposure. Neoplasms in rats were reported
following subcutaneous, intramuscular and intraprostatic
cadmium injection, while respiratory tumors in rats
developed from inhalation. Occupational exposures of
workers in battery and metal smelting industries have been
linked to prostate, kidney and lung cancers, however
smoking could have been a factor in these studies as well
(Nordberg et al. 1992). Another study on trace elemental
analysis of carcinoma kidney and stomach also reported an
elevated cadmium level in the cancer tissue of kidney than
the in the normal (Reddy et al. 2003). Studies have shown
that cadmium have no essential functions in human body
and can produce toxic effects even at very low dose
(Binner et al. 1983). This toxicity results from both
extracellular and intracellular interaction between cad-
mium and the biological system. Cadmium acts as an
inhibitor of sulfydryl enzymes and also has got affinity for
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other cell ligands like hydroxyl, carboxyl, phosphatyl,
cysteinyl and hystidyl side chains of protein, and as such
can disrupt pathways of oxidative phosphorylation (Dara
1997). Since there is no homeostatic control of cadmium in
the human body, it is highly toxic trace element. The target
organ which is the kidney stores more than a third of all
absorbed cadmium in the body. When high amounts of
Cd2? are introduced into the body, it replaces Zn2? at the
key enzyme sites causing metabolic disorders. Other toxic
effects include respiratory disorders, damage to the kidney
and development of kidney stones.
The carcinogenic activity of cadmium varies in different
studies. While some in vitro studies have shown that cad-
mium induces DNA strand breaks, DNA–protein cross-
links, oxidative DNA damage and chromosomal aberra-
tions, mostly at high cytotoxic concentrations (Mouron
et al. 2001). Other studies, however, show that it modulate
the expression of pro-oncogenes (Waisberg et al. 2003),
and inhibit the function or expression of the DNA repair
systems (Giaginis et al. 2006). While the main ROS
responsible for oxidative DNA damage in cells appears to
be hydroxyl radicals generated by the reaction of reactive
transition metal ions, such as Fe2? and Cu2? with H2O2
(Henle and Linn 1997), cadmium is not redox active but
contributes indirectly to oxidative stress by affecting the
cellular thiol redox balance (Nzengue et al. 2008). Other
studies have shown that cadmium indirectly generates ROS
and consequently DNA, lipid and protein oxidation in
various cell lines, which lead to DNA damage and hence
tumor growth (Wang et al. 2004).
Chromium and chromium compounds
Chromium is a naturally occurring element in rocks, ani-
mals, plants, soil and volcanic dust and gases. Chromium
predominantly occurs in the environment in one of two
valence states: trivalent chromium (Cr III), which occurs
naturally and is an essential dietary nutrient needed for to
normal glucose, protein and fat metabolism, and hexava-
lent chromium (Cr VI), which, along with the less common
metallic chromium (Cr 0), is most often produced by
industrial processes (ATSDR 1998). Ferrochrome produc-
tion industries including ore refining, chemical and
refractory processing, cement-producing plants, automo-
bile brake lining and catalytic converters for automobiles,
leather tanneries and chrome pigments are mostly linked to
the atmospheric burden of chromium (USEPA 1998).
Humans are exposed to chromium (generally chromium
[III]) by eating food, drinking water and inhaling air that
contains the chemical with the average daily intake from
air, water and food estimated to be less than 0.2–0.4, 2.0
and 60 lg, respectively (ATSDR 1998). Dermal exposure
to chromium may occur during the use of consumer
products that contain chromium, such as wood treated with
copper dichromate or leather tanned with chromic sulfate
can lead to dermal exposure.
There is little evidence for the carcinogenicity of
metallic chromium and trivalent chromium compounds in
humans. Cr(III) is actually an essential human nutrient
required to promote the insulin action for utilization of
sugars, proteins and fats. It increases the insulin binding to
cells, insulin receptor number and also activates the insulin
receptor kinase which in effect increases insulin sensitivity.
However, there is sufficient evidence that hexavalent
chromium compounds are carcinogenetic. These com-
pounds include: calcium chromate, zinc chromate, stron-
tium chromate and lead chromate. Occupational exposure
to these hexavalent chromium compounds in chromate
production, chromate pigment production and chromium
plating industries have been linked to the cancer of the
lung, nose and nasal sinuses (Boffetta 1993).
Chromium ions is most carcinogenic in the form of
CrO24 , which enters the body cell by sulfate uptake path-
way and is ultimately reduced to Cr(III) through a Cr(IV)-
glutathione intermediate species. The hexavalent latter
complex then binds with the DNA to produce a kinetically
inert and potentially damaging lesion and can cause
abnormal phenotype due to the formation of ROS (Bertini
et al. 1998). Chromium is also believed to repress p53, a
suppressor protein whose inactivation through mutations is
associated with many types of human cancers. The p53
protein is essential for many biological processes including
regulation of genes involved in cell cycle, cell growth
arrest after DNA damage and apoptosis (Hollstein et al.
1994). The reactive chromium intermediates like Cr(V) and
Cr(IV) generate OH radicals which cause DNA strand
breaks, base modification, lipid peroxidation and nuclear
transcription factor NF-kB activation. This also inactivates
p53which alters the process of p53-dependent cell cycle
arrest and apoptosis eventually enhancing cancer devel-
opment (Wang et al. 2000). The unstable intermediate
Cr(V) and Cr(IV) ions also activates oxygen agents and
thiyl and organic radicals (RS and R), which are
responsible for the DNA and other observed cellular
damage.
Cobalt and cobalt compounds
Most of the Earth’s natural cobalt is located in its core.
Cobalt exists in relatively low abundance in the Earth’s
crust and in natural waters, from which it is precipitated as
the highly insoluble cobalt sulfine (CoS). The soil content
of cobalt ranges from 0.1 to 70 ppm in other areas with an
average of about 8 ppm. The blue green algae (cyanobac-
teria) in marine environments and other nitrogen fixing
90 3 Biotech (2013) 3:85–96
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organisms use cobalt. Cobalt is not found as a free metal
and is generally found in the form of ores. Cobalt is usually
not mined as a free metal but rather in ores usually as a by-
product of nickel and copper mining activities with its main
ores being cobaltite, erythrite, glaucodot and skutterudite.
Human exposure occurs through inhalation of cobalt in air,
drinking water and eating food that contains cobalt. Skin
contact with soil or water that contains cobalt may also be
an exposure agent. Plants uptake may also increase accu-
mulation of cobalt in plants and hence animals that feed on
them. Cobalt is essential for human health since it is a part
of vitamin B12. Due to its ability to stimulate red blood
cells, cobalt is also used in the treatment of anemia in
pregnant women. However, occupational exposure to high
concentrations of cobalt may have led to lung effects, such
as asthma and pneumonia.
The International Agency for Research on Cancer
(IARC) has listed cobalt and cobalt compounds within
group 2B (agents which are possibly carcinogenic to
humans). Metallic cobalt and bivalent cobalt oxide was
found to be carcinogenic in experimental animals (rats) at a
relatively high dose, by route(s), histologic type(s) or by
mechanism(s) that are not considered relevant to worker
exposure. However, other cobalt compounds including
bivalent cobalt sulfide, and bivalent cobalt chloride had
limited carcinogenic evidence in experimental animals
after subcutaneous or intramuscular administration (Boff-
etta 1993). Bivalent and trivalent cobalt oxide, cobalt
nephthenate and trivalent cobalt acetate had shown insuf-
ficient evidence of carcinogenicity in experimental ani-
mals. Humans with implants of cobalt containing
prostheses reported increased risk of sarcomas and blood
neoplasms. Occupational exposure epidemiological studies
reported increased risk of lung cancer (IARC 1991).
Studies have shown that in the presence of hydrogen
peroxide, micromolar concentrations of cobalt (II) ions can
cause chemical damage to DNA bases in chromatin,
probably through the production of hydroxyl radicals in
vitro in human lymphocytes and isolated DNA (Lloyd et al.
1997; Nackerdien et al. 1991). The ROS generation by
cobalt (II) from H2O2 and related in vitro DNA damage
was investigated with electron spin resonance, electro-
phoretic assays, and high performance liquid chromatog-
raphy. The same study showed that the oxidation potential
of cobalt (II) can be modulated by chelators to facilitate or
reduce its capacity to generate ROS from hydrogen per-
oxide (H2O2), for instance, the study found that anserine
enhanced the capacity of cobalt (II) to generate radicals,
while deferoxamine reduced it (Mao et al. 1996). Other
studies have shown that cobalt ions substitute for zinc in
protein–zinc finger domains, which control the transcrip-
tion of several genes generate free radicals close to DNA,
causing DNA damage in the process while others indicate
that cobalt ions affect the repair of DNA damage induced
by other agents in mammalian cells (Sarkar 1995; Hartwig
et al. 1991).
Lead and inorganic lead compounds
Lead occurs naturally as a pure metal found in small
amounts in the earth’s crust. Lead can also be found in
plants, animals, air, water, dust and soil. Lead exists both
as a free metal and also in various compounds. In organic
lead compounds, such as tetraethyl lead and tetramethyl
lead, are combined with carbon groups while lead oxide
and lead chloride, are combinations of lead with other
elements. Human exposure is mainly by inhalation from
dust or fumes and by swallowing. Due to its widespread
uses, more environmental exposures are from man-made
rather than natural sources.
Inorganic lead salts, with ionic bonds like lead acetate,
have different chemical properties and toxicological effects
compared to organolead compounds, with covalent bonds
like tetraethyl lead. Several epidemiological and animal
experimental works suggest that inorganic lead compounds
are associated with increased risks of tumorigenesis. Lead
acetate, lead sub-acetate and lead phosphate have been
found to cause tumors in the kidneys of rats and mice
(IARC 1997). In rats, the carcinogenic risks of lead com-
pounds can be induced at doses that are not associated with
organ toxicity and in mice that do not produce a-2 urinary
globulin in the kidney. The kidney, particularly the tubule
epithelium of the renal cortex, is the principal target organ
for the carcinogenicity of lead salts in animals, irrespective
of the route of administration. Since renal epithelial tumors
are very rare in untreated rats and mice of both sexes, even
low incidences of these neoplasms in lead treated animals
are good indicators of a carcinogenic effect (IARC 1980,
1987).
Most observed mechanisms of lead carcinogenicity
include direct DNA damage, clastogenicity, or inhibition of
DNA synthesis or repair (Landolph 1994; Hartwig et al.
1990). Lead can also cause the generation of ROS and
cause oxidative damage to DNA. Other studies have shown
that lead can substitute for zinc in several proteins that
function as transcriptional regulators, including protamines
(Quintanilla-Vega et al. 1997), hence reducing the binding
of these proteins to the recognition elements in genomic
DNA, a process which suggests an epigenetic involvement
of lead in altered gene expression. These events may be of
particular relevance in transplacental exposures and later
cancer. Lead–zinc interactions in proteins can also cause
post-translational changes in protein structure. The tumor
suppressor protein p53 is a zinc-binding protein and thus if
zinc is displaced by lead in p53, may result in a structurally
altered form of the protein with functional consequences
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not different from mutation or deletion of the p53 gene as
has been found for cadmium (Hainaut and Milner 1993).
Occupational exposures have been linked to increase risk
of lung stomach, kidney and bladder cancers in humans.
Nickel and nickel compounds
Most nickel on Earth mainly found in the iron–nickel
molten core, which is 10 % nickel. Nickel is easily
absorbed by organic matter which explains why coal and
oil contain considerable amounts. The soil’s nickel content
ranges between 0.2 and 450 ppm in some clay and loamy
soils with an average of about 20 ppm. Nickel occurs in
some beans where it is an essential component of some
enzymes and in tea which has 7.6 mg/kg of dried leaves.
Nickel occurs combined with sulfur in millerite, with
arsenic in the mineral niccolite and with arsenic and sulfur
in nickel glance. Most ores from which nickel is extracted
are iron–nickel sulfides, such as pentlandite. Other sources
of nickel include chocolate and fats, vegetables grown in
contaminated soils as well as tobacco products. Humans
are exposed to nickel through inhalation, drinking con-
taminated water, eating food or smoking cigarettes and skin
contact with nickel-contaminated soil or water. In small
quantities nickel is essential, but when the uptake is too
high it can be a danger to human health.
Occupational exposure to nickel occurs in industries that
include: high temperature oxidation of nickel matte and
nickel–copper matte, electrolytic refiners, copper plants
and during nickel salt extraction in the hydrometallurgical
industry. Epidemiological studies among nickel refinery
workers exposed to nickel sulfate and a combination of
nickel sulfides and oxides showed high risk of nasal cancer,
larynx cancer, prostate cancer and lung cancer (Boffetta
1993). The chromosomal damage caused by carcinogenic
nickel compounds (crystalline nickel sulfide and nickel
chloride) has been found to be consistent with their car-
cinogenicity and is affected by many factors, including the
exposure concentration and duration (Sunderman 1989). A
study also found that the chromosomal damage induced by
in vitro exposure of Chinese Hamster Ovary (CHO) cells to
carcinogenic nickel compounds preferably occurs in the
heterochromatic regions, which contain more proteins and
exist in a higher-condensed state. These findings could be
explained by the high binding affinity of nickel ions for
protein and the low affinity for DNA (Sen and Costa 1986).
Most nickel ions in the cell nucleus preferentially interact
with the histone, other than DNA, indicating the signifi-
cance of nickel–protein interaction in the mechanism of
nickel carcinogenesis. On the other hand, studies on the
direct effect of nickel ions on DNA found that nickel
ions could enhance the oxidation, hydroxylation and
deglycosylation.
Of DNA bases (deoxynucleosides and deoxynucleo-
tides) induced by active oxygen species (Datta et al. 1991;
Littlefield et al. 1991). The most common DNA damage
that occurs following the binding of DNA or protein with
nickel includes: DNA strand breaks and DNA–protein, and
DNA-interstrand crosslinks. The nickel compounds that
have been found to be carcinogenic in experimental ani-
mals include metallic nickel, nickel monoxides, nickel
hydroxides and crystalline nickel sulfides (Boffetta 1993).
Other elements
There are other elements that have been classified as car-
cinogenic both in humans and experimental animals. The
role of zinc as a carcinogenic agent is still subject to
controversy. Zinc binding may be related to carcinogenesis
since the metal does affect catabolic or anabolic enzymes.
The role of zinc in RNA and DNA polymerase, its inhib-
itory effects on phosphodiesterase, and its activating role
on membrane bound adenyl cyclase all points to the role of
zinc in carcinogenesis (Schwartz 1975). While some
studies have reported growth of local tumors at the site of
injection of copper chloride and copper sulfate in experi-
mental animals, negative results with metallic copper,
copper acetate and copper sulfide have been reported
(Boffetta 1993). Copper is believed to be the switch that
turns on the angiogenesis process in tumor cells. Abnor-
mally high serum copper levels are found in patients with
many types of progressive tumors, making copper an
obligatory cofactor in angiogenesis process. Copper-bind-
ing molecules (ceruloplasmin, heparin, and tripeptide gly-
cly-histadyl-lysine) are non-angiogenic when free of
copper, but they become angiogenic when bound to copper.
As such, anti-copper drugs have been used cancer treat-
ment (Brem et al. 1990). Cisplastin which is a platinum
compound is known to cause leukemia in rats and lung and
skin tumors in mice (IARC 1993). Selenium is an anti-
carcinogen. Some selenoproteins show that they are rele-
vant in scavenging ROS and reducing oxidative damage,
while at times, there has been a strong inverse association
between high serum selenium levels and pancreatic cancer
risks.
The way forward
The mechanistic effects of trace elements in carcinogenesis
cannot be fully understood without further exploring the
critical genetic events across the spectrum of human
tumors with adequate sensitivity and scalability. To this
end, new technologies have been developed in an attempt
to define the spectrum of mutations, expression changes
and other factors that are related to trace element carcin-
ogenicity. Some of these technologies include:
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1. High throughput or new generation sequencing Due
to high demand for revolutionary DNA sequencing tech-
nologies that can deliver fast, inexpensive and accurate
genome information, the recent years have seen a shift
from the application of automated Sanger sequencing for
genome analysis to a newer methods referred to as next-
generation sequencing (NGS). The NGS technologies are
not only cheap but also capable of producing enormous
volume of data—sometimes in excess of one billion short
reads per instrument run. The NGS technologies constitute
various strategies that rely on a combination of template
preparation, sequencing and imaging, and genome align-
ment and assembly methods. The broadest application of
NGS has been the re-sequencing of human genomes, to
enhance the understanding of how genetic differences
affect health and disease.
Studies have been done using high-throughput geno-
typing to query over 238 known oncogene mutations across
human tumor samples establishing a robust mutation dis-
tributions spanning over 17 cancer types (Roman et al.
2007). Of the 17 oncogenes analyzed, the study found 14 to
be mutated at least once and that 30 % samples carried at
least one mutation in addition to identifying a previously
unrecognized oncogene mutations in several tumor types as
well as observing an unexpectedly high number of co-
occurring mutations. These results shone a new light in
tumor genetics, where mutations involving multiple cancer
genes may be interrogated simultaneously and in ‘real
time’ to guide cancer classification and rational therapeutic
intervention. High throughput sequencing also provides an
alternative splicing complexity in human tissues using
mRNA-Seq data, which provides more reliable measure-
ments for exon inclusion levels. New splice junctions,
many of which are tissue-specific, can be detected in
approximately 20 % of multiexon genes (Qun et al. 2008).
Targeted RNA-Seq can also combine NGS with capture of
sequences from a relevant subset of a transcriptome
through testing by capturing sequences from a tumor
cDNA library with hybridization to oligonucleotide when
probing specific cancer-related genes (Joshua et al. 2009).
This method showed high selectivity, improved mutation
detection enabling discovery of novel chimeric transcripts
and provided RNA expression data.
2. Gene expression profiling Gene expression profiling
is the measurement of the activity (the expression) of
thousands of genes at once, by differentiating cells that are
actively dividing, or showing how the cells react to a
particular treatment to create a global picture of cellular
function. Expression profiling experiments involves mea-
suring the relative amount of mRNA expressed in two or
more experimental conditions since altered levels of a
specific sequence of mRNA suggest a changed need for the
protein coded for by the mRNA, which may probably
indicate a homeostatic response or a pathological condi-
tion. For instance, if a given cancer cells express higher
levels of mRNA associated with a specific transmembrane
receptor (specialized integral membrane proteins that take
part in communication between the cell and the outside
world) than normal cells do, it might signal that this
receptor plays a role in that specific cancer type.
The detection of circulating tumor cells (CTCs) in the
peripheral blood and microarray gene expression profiling
of the primary tumor are two promising new technologies
that have been shown to provide valuable prognostic pro-
file data for patients with breast cancer (Molloy et al.
2012). The study was able to develop a unique microarray
signature that can accurately predict CTC status in breast
cancer patients based on gene expression in the primary
tumor, which was not only independent of other clinical
variables, but also MammaPrint, a prognostic microarray
test used in the clinic for breast cancer patients (Molloy
et al. 2012). Another study also used gene expression
profiling for ER? breast cancer prognosis among patients.
Four microarray datasets were combined and research-
based versions of PAM50 intrinsic subtyping and risk of
relapse (PAM50-ROR) score, 21-gene recurrence score
(OncotypeDX), Mammaprint, Rotterdam 76 gene, index of
sensitivity to endocrine therapy (SET) and an estrogen-
induced gene set were evaluated. All signatures were
prognostic in patients with ER? node-negative tumors,
whereas most were prognostic in ER? node-positive dis-
ease (Prat et al. 2012).
3. Proteomics Proteomics is the large-scale study of the
identity, structural roles and biochemical functions of
proteins, a vital part of living organism which is the main
components of the physiological metabolic pathway of cell.
Proteomics uses various biomarkers for disease diagnosis.
The Proteomics techniques, which allow to test for proteins
produced during a particular disease, hence helping to
diagnose the disease quickly includes: western blot,
immunohistochemical staining, enzyme linked immuno-
sorbent assay (ELISA) also known as mass spectroscopy
and secretomics (Klopfleisch et al. 2010; Klopfleisch and
Gruber 2009). Researchers hope that proteomics research is
inclined to help find new ways to diagnose cancer early
(key to successful treatment), identify the best treatments
for individual patients with specific types of cancer and
determine recurrence of cancer after treatment.
The mass spectrometry (MS)-based quantitative pro-
teomics is powerful tool for discovering disease biomarkers
that can provide diagnostic, prognostic and therapeutic
targets, in addition to addressing important problems in
clinical and translational medical research (Liang et al.
2012). The MS-based quantification strategy and technical
advances of several main quantitative assays includes two-
dimensional (2D) gel-based methods, stable isotope
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labeling with amino acids in cell culture (SILAC), isotope-
coded affinity tag (ICAT), the isobaric tags for relative and
absolute quantification (iTRAQ), 18O labeling, absolute
quantitation and label-free quantitation. They have been
widely applied in identification of differential expression of
proteins, post-translational modifications and protein–pro-
tein interactions in order to look for novel candidate cancer
biomarkers from different physiological states of cells,
body fluids or tissue samples (Liang et al. 2012).
Conclusion
Since most of the elements that are carcinogenic are either
naturally or through human activity present in the envi-
ronment, awareness through public health information is
necessary to reduce possible exposure that can affect
thousands of human health. This information is also
essential to create awareness and reduce occupational
exposures to large populations that work directly in related
industries as well as highlighting the effects of habits like
smoking (both active and passive), which exposes indi-
viduals to more carcinogenic trace element cadmium. This
review helps outline the main carcinogenic elements, their
sources and exposure means and their carcinogenic effects
which are essential for preventive purposes. More epide-
miological data is necessary to understand the carcinogenic
and anti-carcinogenic effects of these elements. Since
certain cancer types vary with race, age group, organ, sex,
heredity and environmental factors, generalization is not
possible all the time. The use of the more advanced technol-
ogies some of which are discussed in the way forward section
with the ability to analyze and compare large data quantities in
real time can enhance the prognostic roles of trace elements
among the global genetically and environmentally diverse
populations with reliable accuracy. For instance, both gene
expression profiling and proteomics have the potential diag-
nosis and identification of the best treatments for individual
patients with specific types of cancer.
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